PACAP and its receptor PAC1 can protect cells from apoptosis

ationship between RRM1 and GC aggressiveness, we measured p-ERK in 32 GC patients’ paraffin samples. The IHC staining indicated that RRM1 expression was concordantly associated with p-ERK level in GC samples. The correlation was statistically significant. Furthermore, gene transferring experiment indicated that higher RRM1 expression increased pERK expression in AGS cells and promoted cell growth in vitro. To determine whether RRM1 regulates Ras/Raf/MAPK signaling, we down-regulated RRM1 expression by siRNA in AGS and NCI-N87 cells. Scramble siRNA was used as a negative control. Western blot analysis indicated that RRM1 was specifically reduced by the corresponding siRNA. Along with a reduction of RRM1, the 20814247 signals for p-MEK, p-ERK and NF-kB were decreased significantly; Ras/Raf activity also dropped remarkably in both AGS and NCI-N87 cells. The above observations illustrate that RRM1 may promote GC cell proliferation by activating Ras/Raf/ MAPK signaling. Measurement of the dNTP Pool This assay was conducted according to the method of Sherman and Fyfe. The total reaction volume was 50 mL. The reaction mixture contained 10 mM MgCl2, 0.25 mM template/primer, 50 mM Tris-HCl, 5 mM DTT, 1.25 mM dATP or dTTP and 0.2 units of Sequenase. The reaction mixture was incubated at room temperature for 20 minutes, and then the reaction was stopped on ice. After the reaction, 40-mL aliquots were removed and spotted onto circular Whatman DE81 Indirubin-3′-oxime biological activity ion-exchange papers. The papers were dried, washed with 5% Na2HPO4, and rinsed once with distilled water and once more with 95% ethanol. Each paper was dried and deposited into a small test tube; 7 mL of Ecolume was then added to each tube. A liquid scintillation counter was used to count the tritiumlabeled dNTPs. The standard samples were 0.25, 0.5, 0.75 and 1.0 pmol. RRM1 Expression is Associated with Gastric Cancer Aggressiveness To further explore the above findings, RRM1 protein expression was measured in the GC samples. Based on the IHC staining, 22 of 67 GCs in the COH set and 156 of 322 GCs in the ZJU set were either cytoplasmic or nuclear RRM1-high. In the COH and ZJU sets, RRM1-high was more frequent in males than females and more likely to reach statistical significance in the ZJU set. There was more proximal GC in the COH set, but more distal GC in the ZJU set. RRM1 expression was significantly higher in the proximal GCs in the COH set, and a similar trend was observed in the ZJU set. Meanwhile, RRM1 was associated with the number of lymph nodes involved, tumor size, Ki67 expression, histological subtype and histological grade in the ZJU set. Because of the small sample size, no statistical significance for the above factors was observed in the COH set, but similar trends could obviously be seen. To further investigate whether RRM1 was associated with GC aggressiveness, a non-conditional multivariate logistic analysis was conducted. Here, the TNM stage was considered to be the output, and the odds ratio for RRM1 was adjusted for co-factors, including age, sex, tumor location and histological grade. The adjusted OR for RRM1 was 1.78 in the ZJU set. These results indicate that high RRM1 expression was associated with advanced TNM stage in 14552791 GC. Results Validation of the Specificity of the RRM1 Antibodies in the Gastric Adenocarcinoma Samples The specificity of the RRM1 antibodies was validated by a peptide blocking assay. The antibodies were diluted, preincubated with recombinant RRM1 peptide at 4uC overni